Oscon presentation
Novel orally active inhibitors of passive cutaneous anaphylaxis in rats: N-[2-(4-Pyridinyl)-4-pyrimidinyl] ureas and dialkyl [[[2-(4-pyridinyl)-4-pyrimidinyl]amino]methylene]malonates
![Novel orally active inhibitors of passive cutaneous anaphylaxis in rats: N-[2-(4-Pyridinyl)-4-pyrimidinyl] ureas and dialkyl [[[2-(4-pyridinyl)-4-pyrimidinyl]amino]methylene]malonates](https://static.fdocuments.us/doc/330x215/5750a3c21a28abcf0ca522d5/novel-orally-active-inhibitors-of-passive-cutaneous-anaphylaxis-in-rats-n-2-4-pyridinyl-4-pyrimidinyl.jpg)
